Depression in Patients with Heart Disease: The Case for More Trials

• Thombs BD , BassEB, FordDEet al.: Prevalence of depression in survivors of acute myocardial infarction.J. Gen. Intern. Med.21 , 30–38 (2006).
   PubMed Web of Science ®Google Scholar
• Rutledge T , ReisVA, LinkeSE, GreenbergBH, MillsPJ: Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes.J. Am. Coll. Cardiol.48 , 1527–1537 (2006).
   PubMed Web of Science ®Google Scholar
• Frasue-Smith N , LespéranceF: Depression and cardiac risk: present status and future directions.Heart96(3) , 173–176 (2010).
   PubMedGoogle Scholar
• Carney RM , FreedlandKE: Depression and heart rate variability in patients with coronary heart disease.Cleve. Clin. J. Med.76(Suppl. 2) , S13–S17 (2009).
   PubMedGoogle Scholar
• Markovitz JH , ShusterJL, ChitwoodWS, MayRS, TolbertLC: Platelet activation in depression and effects of sertraline treatment: an open-label study.Am. J. Psychiatry157 , 1006–1008 (2000).
   PubMed Web of Science ®Google Scholar
• Serebruany VL , GlassmanAH, MalininAIet al.: Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials.Blood Coagul. Fibrinolysis14 , 563–567 (2003).
   PubMed Web of Science ®Google Scholar
• Hughes JR , HatsukamiDK, MitchellJE, DahlgreenLA: Prevalence of smoking among psychiatric outpatients.Am. J. Psychiatry143 , 993–997 (1986).
   PubMed Web of Science ®Google Scholar
• Laje RP , BermanJA, GlassmanAH: Depression and nicotine: preclinical and clinical evidence for common mechanisms.Curr. Psychiatry Rep.3 , 470–474 (2001).
   PubMedGoogle Scholar
• Paperwalla KN , LevinTT, WeinerJ, SaravaySM: Smoking and depression.Med. Clin. North Am.88 , 1483–1494 (2004).
   PubMed Web of Science ®Google Scholar
• Kamphuis MH , GeerlingsMI, TijhuisMARet al.: Physical inactivity, depression, and risk of cardiovascular mortality.Med. Sci. Sports Exerc.39 , 1693–1699 (2007).
   PubMed Web of Science ®Google Scholar
• DiMatteo MR , LepperHS, CroghanTW: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.Arch. Intern. Med.160 , 2101–2107 (2000).
   PubMed Web of Science ®Google Scholar
• Gehi A , HaasD, PipkinS, WhooleyMA: Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study.Arch. Intern. Med.165 , 2508–2513 (2005).
   PubMed Web of Science ®Google Scholar
• Coronary Drug Project Research Group: Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N. Engl. J. Med.303 , 1038–1041 (1980).
   PubMed Web of Science ®Google Scholar
• Horwitz RI , ViscoliCM, BerkmanL: Treatment adherence and risk of death after a myocardial infarction.Lancet336 , 542–545 (1990).
   PubMed Web of Science ®Google Scholar
• Irvine J , BakerB, SmithJ: Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.Psychosom. Med.61 , 566–575 (1999).
   PubMed Web of Science ®Google Scholar
• Granger BB , SwedbergK, EkmanI: Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.Lancet366 , 2005–2011 (2005).
   PubMed Web of Science ®Google Scholar
• Glassman AH , O‘ConnorCM, CaliffRMet al.; Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA288 , 701–709 (2002).
   PubMed Web of Science ®Google Scholar
• Honig A , KuyperAM, ScheneAHet al.; MIND-IT Investigators: Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom. Med.69 , 606–613 (2007).
   PubMed Web of Science ®Google Scholar
• Berkman LF , BlumenthalJ, BurgMet al.; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD): Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA289 , 3106–3116 (2003).
   PubMed Web of Science ®Google Scholar
• van Melle JP , de Jonge P, Honig A; MIND-IT Investigators: Effects of antidepressant treatment following myocardial infarction. Br. J. Psychiatry190 , 460–466 (2007).
   PubMed Web of Science ®Google Scholar
• Lichtman JH , BiggerJT Jr, Blumenthal JA et al.; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association: Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation118 , 1768–1775 (2008).
   PubMed Web of Science ®Google Scholar
• Pozuelo L , TesarG, ZhangJ, PennM, FrancoK, JiangW: Depression and heart disease: what do we know, and where are we headed?Cleve. Clin. J. Med.76 , 59–70 (2009).
   PubMed Web of Science ®Google Scholar
• Glassman AH , BiggerJT Jr, Gaffney M: Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch. Gen. Psychiatry66 , 1022–1029 (2009).
   PubMed Web of Science ®Google Scholar
• Ballenger JC , DavidsonJR, LecrubierY, NuttDJ, RooseSP, Sheps DS; International Consensus Group on Depression and Anxiety: Consensus statement on depression, anxiety, and cardiovascular disease. J. Clin. Psychiatry62(Suppl. 8) , 24–27 (2001).
   PubMedGoogle Scholar
• US Preventive Services Task Force: Screening for depression in adults: US preventive services task force recommendation statement. Ann. Intern. Med.151 , 784–792 (2009).
   PubMed Web of Science ®Google Scholar
• Wu SY , NemesureB, HennisA, SchachatAP, HymanL, Leske MC; Barbados Eye Studies Group: Open-angle glaucoma and mortality: the Barbados Eye Studies. Arch. Ophthalmol.126 , 365–370 (2008).
   PubMedGoogle Scholar
• Lee AJ , WangJJ, KifleyA, MitchellP: Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.Ophthalmology113 , 1069–1076 (2006).
   PubMed Web of Science ®Google Scholar
• Tan JS , WangJJ, LiewG, RochtchinaE, MitchellP: Age-related macular degeneration and mortality from cardiovascular disease or stroke.Br. J. Ophthalmol.92 , 509–512 (2008).
   PubMed Web of Science ®Google Scholar
• Rumsfeld JS , HoPM: Depression and cardiovascular disease: a call for recognition.Circulation111 , 250–253 (2005).
   PubMed Web of Science ®Google Scholar
• Yarnall KS , PollakKI, ØstbyeT, KrauseKM, MichenerJL: Primary care: is there enough time for prevention?Am. J. Public Health93 , 635–641 (2003).
   PubMed Web of Science ®Google Scholar
• Schneiderman N , SaabPG, CatellierDJet al.; ENRICHD Investigators: Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom. Med.66 , 475–483 (2004).
   PubMed Web of Science ®Google Scholar
• Freedland KE , CarneyRM, LustmanPJ, RichMW, JaffeAS: Major depression in coronary artery disease patients with vs. without a prior history of depression.Psychosom. Med.54 , 416–421 (1992).
   PubMed Web of Science ®Google Scholar
• Grace SL , AbbeySE, KapralMK, FangJ, NolanRP, StewartDE: Effect of depression on five-year mortality after an acute coronary syndrome.Am. J. Cardiol.96 , 1179–1185 (2005).
   PubMed Web of Science ®Google Scholar
• de Jonge P , van den Brink RH, Spijkerman TA, Ormel J: Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J. Am. Coll. Cardiol.48 , 2204–2208 (2006).
   PubMed Web of Science ®Google Scholar
• Saab PG , BangH, WilliamsRBet al.; ENRICHD Investigators: The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. J. Psychosom. Res.67 , 45–56 (2009).
   PubMed Web of Science ®Google Scholar
• Rollman BL , BelnapBH, LeMenagerMSet al.: Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial.JAMA302 , 2095–2103 (2009).
   PubMed Web of Science ®Google Scholar
• Fournier JC , DeRubeisRJ, HollonSDet al.: Antidepressant drug effects and depression severity: a patient-level meta-analysis.JAMA303 , 47–53 (2010).
   PubMed Web of Science ®Google Scholar
• Kirsch I , DeaconBJ, Huedo-MedinaTB, ScoboriaA, MooreTJ, JohnsonBT: Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.PLoS Med.5 , E45 (2008).
   PubMed Web of Science ®Google Scholar
• Holme I : An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.Circulation82 , 1916–1924 (1990).
   PubMed Web of Science ®Google Scholar
• Gould AL , RossouwJE, SantanelloNC, HeyseJF, FurbergCD: Cholesterol reduction yields clinical benefit. A new look at old data.Circulation91 , 2274–2282 (1995).
   PubMed Web of Science ®Google Scholar
• Gould AL , RossouwJE, SantanelloNC, HeyseJF, FurbergCD: Cholesterol reduction yields clinical benefit: impact of statin trials.Circulation97 , 946–952 (1998).
   PubMed Web of Science ®Google Scholar
• Cohen HW , GibsonG, AldermanMH: Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.Am. J. Med.108 , 2–8 (2000).
   PubMed Web of Science ®Google Scholar
• Glassman AH , RooseSP, BiggerJT Jr: The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA269 , 2673–2675 (1993).
   PubMed Web of Science ®Google Scholar
• Roose SP , Laghrissi-ThodeF, KennedyJSet al.: Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.JAMA279 , 287–291 (1998).
   PubMed Web of Science ®Google Scholar
• Thombs BD , de Jonge P, Coyne JC et al.: Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA300 , 2161–2171 (2008).
   PubMed Web of Science ®Google Scholar
• Ioannidis JP : Adverse events in randomized trials: neglected, restricted, distorted, and silenced.Arch. Intern. Med.169 , 1737–1739 (2009).
   PubMed Web of Science ®Google Scholar
• Whang W , KubzanskyLD, KawachiIet al.: Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses‘ Health Study.J. Am. Coll. Cardiol.53 , 950–958 (2009).
   PubMed Web of Science ®Google Scholar
• Krantz DS , WhittakerKS, FrancisJLet al.: Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women‘s Ischemia Syndrome Evaluation (WISE) study.Heart95 , 1901–1906 (2009).
   PubMed Web of Science ®Google Scholar
• Smoller JW , AllisonM, CochraneBBet al.: Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women‘s Health Initiative study.Arch. Intern. Med.169 , 2128–2139 (2009).
   PubMed Web of Science ®Google Scholar
• Frasue-Smith N , LespéranceF, PrinceRHet al.: Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction.Lancet350 , 473–479 (1997).
   PubMed Web of Science ®Google Scholar
• Lepérance F , Frasure-SmithN, KoszyckiDet al.; CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA297 , 367–379 (2007).
   PubMed Web of Science ®Google Scholar
• Blumenthal JA , BabyakMA, DoraiswamyPMet al.: Exercise and pharmacotherapy in the treatment of major depressive disorder.Psychosom. Med.69 , 587–596 (2007).
   PubMed Web of Science ®Google Scholar
• Blumenthal JA , SherwoodA, BabyakMAet al.: Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial.JAMA293 , 1626–1634 (2005).
   PubMed Web of Science ®Google Scholar
• de Jonge P , HonigA, van Melle JP et al.; MIND-IT Investigators: Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am. J. Psychiatry164 , 1371–1378 (2007).
   PubMed Web of Science ®Google Scholar
• Carney RM , FreedlandKE: Treatment-resistant depression and mortality after acute coronary syndrome.Am. J. Psychiatry166 , 410–417 (2009).
   PubMed Web of Science ®Google Scholar
• Glassman AH , BiggerJT Jr, Gaffney M: Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression. Seven-year follow-up of SADHART participants. Arch. Gen. Psychiatry66 , 1022–1029 (2009).
   PubMed Web of Science ®Google Scholar
• Jiang W , GlassmanA, KrishnanR, O‘ConnorCM, CaliffRM: Depression and ischemic heart disease: what have we learned so far and what must we do in the future?Am. Heart J.150 , 54–78 (2005).
   PubMed Web of Science ®Google Scholar

Website

• Remarks by the President at the Summit of the Americas Opening Ceremony, 17 April 2009 www.whitehouse.gov/the_press_office/Remarks-by-the-President-at-the-Summit-of-the-Americas-Opening-Ceremony Accessed 24January2010
   Google Scholar